Pharmacology
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
This section essentially covers all aspects of pharmacology, including pharmacodynamics, pharmacokinetics and toxicology. Research papers should provide rigorous quantitative analyses and/or new insights on intermolecular reactions of drugs with chemical constituents of cells, tissues, organs or organ systems.
It publishes high quality original research and authoritative reviews, commentary and letters to the editor. Download Section Flyer
Keywords
- Behavioral pharmacology
- Cancer pharmacology
- Cardiovascular pharmacology
- Chronopharmacology
- Clinical pharmacology
- Immunopharmacology
- Molecular and biochemical pharmacology
- Neuropharmacology
- Pharmacoepidemiology
- Pharmacogenetics/pharmacogenomics
- Pharmacokinetics
- Systems pharmacology
- Toxicology
- Translational pharmacology/medicine
- Safety pharmacology
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Lithium in Psychiatric Therapy: Celebrating 75th Anniversary (Deadline: 25 November 2025)
- Discovery of Novel Antidepressants and Anxiolytics (Deadline: 25 November 2025)
- New Findings in Pharmacogenomics of Neuropsychiatric Disorders (Deadline: 25 November 2025)
- Molecular Mechanisms and Treatment of Brain Cancer: Recent Advances and Future Trends (Deadline: 25 November 2025)
- New Development in Pharmacotherapy of Kidney Diseases (Deadline: 25 November 2025)
- Pediatric Drug Therapy: Safety, Efficacy, and Personalized Medicine (Deadline: 25 November 2025)
- Novel Therapeutic Strategies for Alzheimer’s Disease Treatment (Deadline: 25 November 2025)
- Pharmaceutical Approaches to Orofacial Pain and Chronic Pain Conditions (Deadline: 25 November 2025)
- Epithelial Plasticity and Therapy Resistance in Cancer (Deadline: 25 November 2025)
- Pharmacovigilance Insights: Addressing Drug Misuse and Enhancing Drug Safety (Deadline: 25 November 2025)
- Pharmacology and Toxicology of Opioids, 2nd Edition (Deadline: 25 November 2025)
- Antimicrobial Therapies Affect the Microbial Ecosystems Within Our Body: The Urinary Microbiome and Urolithiasis (Deadline: 25 November 2025)
- Next-Generation Targeted Therapy: vNARs as Drug Carriers and Intracellular Neutralizing Agents (Deadline: 28 November 2025)
- New Insights of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Biomedical Applications (Deadline: 30 November 2025)
- Advances in Antibody–Drug Conjugates (Deadline: 30 November 2025)
- Comprehensive Strategies in Cancer Immunotherapy (Deadline: 30 November 2025)
- Green Synthesis and Biological Applications of Metal Nanoparticles Influenced by Different Seasonal Periods (Deadline: 30 November 2025)
- Pharmacological Strategies to Modulate Symptoms in Autism Spectrum Disorders (ASD) (Deadline: 30 November 2025)
- Population Pharmacokinetics and Pharmacogenetics (Deadline: 10 December 2025)
- New Advances in Antiarrhythmic Drugs (Deadline: 15 December 2025)
- Management of Pain in Oral Mucositis (Deadline: 20 December 2025)
- Recent Advances in Cancer Diagnosis and Therapy (Deadline: 25 December 2025)
- Cancer Pain—from Novel Mechanisms to Clinical Management (Deadline: 25 December 2025)
- Treatment for HPV-Associated Cervical Cancer: Novel Therapeutic Strategies (Deadline: 25 December 2025)
- Pharmacotherapy of Endometriosis (Deadline: 31 December 2025)
- Pharmacology of Heart Failure (Deadline: 31 December 2025)
- Advancing Cardio-Oncology: Mechanisms of Cardiotoxicity and Therapeutic Options for Old and New Anticancer Drugs (Deadline: 31 December 2025)
- Advances in Smooth Muscle Pharmacology (Deadline: 31 December 2025)
- Drug Target Exploration and Drug Design & Development Based on Small Molecule (Deadline: 31 December 2025)
- Antibiotic Resistance and Misuse (Deadline: 31 December 2025)
- Applications of Nerve Growth Factor in Pharmaceuticals (Deadline: 31 December 2025)
- Infectious Disease Epidemiology and Pharmaceutical Development in the Era of Antimicrobial Resistance (AMR) (Deadline: 31 December 2025)
- Emerging Therapies for Diabetes and Obesity (Deadline: 15 January 2026)
- The Pharmacology of Bisphosphonates: New Advances (Deadline: 20 January 2026)
- Biological and Pharmacological Research on Indole-3-Carbinol (I3C) and Its Derivatives (Deadline: 20 January 2026)
- Pharmacological Activities and Therapeutic Potential of Novel Drug Derivatives (Deadline: 20 January 2026)
- Pharmacotherapeutics of Sarcoidosis (Deadline: 20 January 2026)
- The Application of Pharmacogenetics in Toxicity Prevention and Drug Effect Improvement (Deadline: 25 January 2026)
- Pharmacoepidemiology and Pharmacovigilance in Drug Therapy: New Issues, Challenges, and Applications (Deadline: 25 January 2026)
- Research Progress and Drug Intervention Strategies for Oral Health-Related Diseases (Deadline: 25 January 2026)
- Clinical Advances in the Neuropharmacological Treatment of Substance Use Disorders: 2nd Edition (Deadline: 25 January 2026)
- Advances in Drug Treatment for Pediatric Gastroenterology (Deadline: 25 January 2026)
- Pharmacogenomics and Ethnic Diversity: Optimizing Drug Response Across Populations (Deadline: 25 January 2026)
- Pharmacotherapy of Inflammatory Bowel Disease, 2nd Edition (Deadline: 25 January 2026)
- Osteosarcomas: Treatment Strategies, 2nd Edition (Deadline: 26 January 2026)
- Innovative Drug Strategies in Chronic Disease Management: Addressing Non-Adherence and Improving Therapeutic Outcomes (Deadline: 27 January 2026)
- Pharmacological Modulation of Inflammation in Autoimmune Diseases and Cancer (Deadline: 27 January 2026)
- Drug Candidates for the Treatment of Oral Cancer and Oral Cancer Pain, 2nd Edition (Deadline: 27 January 2026)
- Ischemic Stroke: Current and Emerging Treatment Strategies (Deadline: 30 January 2026)
- NeuroImmunoEndocrinology (Deadline: 31 January 2026)
- Novel Therapeutic Targets and Strategies for Drug Addiction and Medication-Induced Toxicity (Deadline: 31 January 2026)
- The Regulatory Roles of the Gut Microbiota in Multisystem Diseases (Deadline: 31 January 2026)
- Novel Drug Candidates for the Treatment of Cardiac and Renal Diseases (Deadline: 31 January 2026)
- Development of Antibacterial Drugs to Combat Drug-Resistant Bacteria: 2nd Edition (Deadline: 31 January 2026)
- Advances in Targeting Mitochondrial Sirtuins for Treatment of Metabolic Diseases Such as Type 2 Diabetes and Obesity (Deadline: 31 January 2026)
- Drug Therapy for Rheumatological Diseases (Deadline: 31 January 2026)
- Advances in Targeted Therapy for Gastrointestinal Cancers (Deadline: 31 January 2026)
- Chemotherapeutic and Targeted Drugs in Antitumor Therapy (Deadline: 15 February 2026)
- Application of Zebrafish Model in Pharmacology and Toxicology (Deadline: 15 February 2026)
- Recent Advances in Ocular Pharmacology (Deadline: 20 February 2026)
- Pharmacotherapy of Macular Diseases (Deadline: 20 February 2026)
- Exploring Biomarkers and Pharmacotherapies for Substance Use Disorders (Deadline: 25 February 2026)
- Neuropsychiatric Disorders: Pharmacological Aspects (Deadline: 25 February 2026)
- Pharmacological Approaches of Chronic Obstructive Pulmonary Disease (COPD) and Lung Cancer (Deadline: 25 February 2026)
- Challenges and Emerging Trends in Photopharmacology (Deadline: 25 February 2026)
- Scientific Evidence-Based Applications of Polyamines in Pharmaceuticals Science (Deadline: 25 February 2026)
- Innovative Approaches to GABAergic Drug Discovery: From Molecular Mechanisms to Advanced Therapeutics (Deadline: 25 February 2026)
- Targeting Epigenetic Regulation for Cancer Therapy (Deadline: 25 February 2026)
- Advances in Perinatal Pharmacology (Deadline: 25 February 2026)
- Drug Treatment for Epilepsy (Deadline: 25 February 2026)
- Adjuvant Therapies for Cancer Treatment: 2nd Edition (Deadline: 27 February 2026)
- New Horizons in Drug Development Targeting Depression (Deadline: 28 February 2026)
- Molecular Insights and Clinical Implications in Geriatric Medicine and Drug Development (Deadline: 28 February 2026)
- Vitamin D and Its Derivatives in Pharmacology: Mechanisms and Therapeutic Applications (Deadline: 28 February 2026)
- The Emerging Field of Critical Care Psychiatry: Pharmacologic Treatment from ICU to Post-ICU Recovery (Deadline: 28 February 2026)
- Applications of Pharmacogenomics in Precision Medicine (Deadline: 28 February 2026)
- Medications: Interactions with Diet, Herbs, Dietary Supplements and Probiotics (Deadline: 1 March 2026)
- Innovations in Chemotherapy: From Synthetic to Natural Agents and Combined Therapies (Deadline: 1 March 2026)
- Advances in Cancer Treatment and Toxicity (Deadline: 10 March 2026)
- Pharmacogenomics and Pediatric Pharmacotherapy (Deadline: 10 March 2026)
- Pharmacokinetics and Pharmacometrics Driving Innovation (Deadline: 12 March 2026)
- Potential Pharmacotherapeutic Targets in Neurodegenerative Diseases (Deadline: 20 March 2026)
- Novel Therapeutic Targets in the Cardiovascular Treatment Landscape (Deadline: 22 March 2026)
- Cholinergic Modulation, Anticholinergic Burden, and Neuroprotection: Mechanisms to Therapeutics (Deadline: 25 March 2026)
- Advances in Prostate Cancer Therapeutics (Deadline: 25 March 2026)
- Melatonin Applications in Pharmaceutical Science (Deadline: 25 March 2026)
- Challenges in Discovering Innovations Related to Biofilms: Virulence, Spread, Control Strategies and Treatment (Deadline: 25 March 2026)
- Pharmacotherapy and Molecular Biomarkers of Metabolic Diseases (Deadline: 25 March 2026)
- Kynurenine Pathway: A Novel Therapeutic Opportunity—2nd Edition (Deadline: 25 March 2026)
- Novel Anti-Obesity Pharmacotherapies (Deadline: 25 March 2026)
- Novel Vasoactive and Anti-Inflammatory Agents: From Mechanisms to Therapeutic Applications (Deadline: 25 March 2026)
- Discovery and Validation of Novel Antimicrobial Molecules for the Treatment of Multidrug-Resistant Bacterial Infections (Deadline: 27 March 2026)
- Advancements in Cardiovascular and Antidiabetic Drug Therapy, 2nd Edition (Deadline: 27 March 2026)
- Exploring the Anticancer and Immunomodulatory Mechanisms of Phytochemicals and Natural Bioactive Compounds (Deadline: 31 March 2026)
- Advances in Antiparasitic Drug Research (Deadline: 31 March 2026)
- Membrane Receptors in Disease: Mechanisms and Targeted Therapeutic Strategies (Deadline: 31 March 2026)
- Advances in Ophthalmic Drug Discovery and Delivery: From Targets to Treatments (Deadline: 10 April 2026)
- Emerging Therapeutics for the Prevention of Chemotherapy-Induced Cardiotoxicity: Advances and Future Perspectives (Deadline: 20 April 2026)
- Recent Advances in Psychopharmacology: 2nd Edition (Deadline: 24 April 2026)
- Targeting Neuromodulators: Effective Therapeutic Strategies for Brain Disorders (Deadline: 24 April 2026)
- Pharmacology of Antidepressants: Recent Advances (Deadline: 25 April 2026)
- Potential Therapeutic Targets for the Management of Diabetes Mellitus, Obesity and Cancer (Deadline: 25 April 2026)
- Emerging Therapeutic Strategies for Heart Diseases (Deadline: 25 April 2026)
- Pharmaceutical and Biomaterial Approaches for Preventive and Restorative Dentistry (Deadline: 25 April 2026)
- New Perspectives in Ocular Pharmacology: 2nd Edition (Deadline: 26 April 2026)
- Fluoroquinolones, 2nd Edition (Deadline: 27 April 2026)
- Tumor Immunopharmacology, 2nd Edition (Deadline: 27 April 2026)
- Innovative Drug Delivery and Mitochondrial-Targeted Therapies (Deadline: 30 April 2026)
- New Trends in the Treatment of Neuropsychiatric Disorders (Deadline: 30 April 2026)
- Computational Predictions of Molecules with Potential Therapeutic Effects: 2nd Edition (Deadline: 30 April 2026)
- The Therapeutic Potential of Neurotrophin Signaling in Neurodegenerative Disorders (Deadline: 30 April 2026)
- Ophthalmic Drugs and Pharmacology (Deadline: 1 May 2026)
- Novel Drug Compositions for Ischemic Stroke: Mechanisms and Clinical Applications (Deadline: 20 May 2026)
- Pharmacogenomics for Precision Medicine, 2nd Edition (Deadline: 23 May 2026)
- Innovations in Therapeutic Strategies for Retinal and Neurodegenerative Diseases (Deadline: 25 May 2026)
- Sirtuins as Novel Biological Targets for Pharmacological Intervention in Physiology and Pathology—2nd Edition (Deadline: 25 May 2026)
- Histamine Receptors: Ligand Design, Pharmacology, and Therapeutic Applications (Deadline: 25 May 2026)
- Impact of Drug Transporter Gene Variation on Pharmacokinetics and Clinical Outcomes in Chronic Disease Therapy (Deadline: 25 May 2026)
- Hepatitis B and Delta Virus Infections: Mechanistic Insights and Clinical Drug Therapy (Deadline: 25 May 2026)
- Research Advances in Targeted Therapy for Facial Skin Diseases (Deadline: 25 May 2026)
- Deregulated Signaling Pathways and Innovative Therapeutic Approaches in Cancer (Deadline: 25 May 2026)
- Precision Oncology: Targeting Molecular Subtypes in Cancer Therapy (Deadline: 29 May 2026)
- Exploring Novel Therapies and Drug Efficacy for Inflammatory Bowel Disease (Deadline: 30 May 2026)
- Applications of Stem Cells and Organoids in Disease Modeling, Drug Discovery and Clinical Evaluation (Deadline: 31 May 2026)
- Epidemiological Surveillance of Clinical Bacterial Infections and Antimicrobial Resistance Management (Deadline: 25 June 2026)
- Therapeutic Potential of Cannabinoid Receptors Type 1 and 2—Novel Insights for Enhancing the Chance of Clinical Success, 2nd Edition (Deadline: 30 June 2026)
- Curcumin: Current Status and Future Challenges in Drug Delivery and Advanced Formulations (Deadline: 30 June 2026)
- Ferroptosis in Cancer and Beyond: Mechanisms, Biomarkers, and Interventions (Deadline: 30 June 2026)
- G-Protein-Coupled Receptors as Therapeutic Targets for CNS Disorders (Deadline: 24 July 2026)
Topical Collections
Following topical collections within this section are currently open for submissions:
